SE513624C2 - Farmaceutiska produkter innehållande en låg halt av denterium, förfarande för framställning därav samt användning av produkterna i samband med behandling av tumörsjukdomar - Google Patents

Farmaceutiska produkter innehållande en låg halt av denterium, förfarande för framställning därav samt användning av produkterna i samband med behandling av tumörsjukdomar

Info

Publication number
SE513624C2
SE513624C2 SE9401406A SE9401406A SE513624C2 SE 513624 C2 SE513624 C2 SE 513624C2 SE 9401406 A SE9401406 A SE 9401406A SE 9401406 A SE9401406 A SE 9401406A SE 513624 C2 SE513624 C2 SE 513624C2
Authority
SE
Sweden
Prior art keywords
ppm
deuterium
water
deuterium content
content
Prior art date
Application number
SE9401406A
Other languages
English (en)
Swedish (sv)
Other versions
SE9401406L (sv
SE9401406D0 (sv
Inventor
Gabor Somlyai
Original Assignee
Hyd Kutato Fejlesztoe Kft
Gabor Somlyai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyd Kutato Fejlesztoe Kft, Gabor Somlyai filed Critical Hyd Kutato Fejlesztoe Kft
Publication of SE9401406D0 publication Critical patent/SE9401406D0/xx
Publication of SE9401406L publication Critical patent/SE9401406L/
Publication of SE513624C2 publication Critical patent/SE513624C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9401406A 1991-10-31 1994-04-25 Farmaceutiska produkter innehållande en låg halt av denterium, förfarande för framställning därav samt användning av produkterna i samband med behandling av tumörsjukdomar SE513624C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases
PCT/HU1992/000036 WO1993008794A1 (fr) 1991-10-31 1992-09-28 Produits pharmaceutiques destines a guerir les maladies tumorales, et leur procede de preparation

Publications (3)

Publication Number Publication Date
SE9401406D0 SE9401406D0 (sv) 1994-04-25
SE9401406L SE9401406L (sv) 1994-06-07
SE513624C2 true SE513624C2 (sv) 2000-10-09

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9401406A SE513624C2 (sv) 1991-10-31 1994-04-25 Farmaceutiska produkter innehållande en låg halt av denterium, förfarande för framställning därav samt användning av produkterna i samband med behandling av tumörsjukdomar

Country Status (22)

Country Link
US (1) US5855921A (fr)
JP (1) JP3569916B2 (fr)
KR (1) KR100253874B1 (fr)
CN (1) CN1045162C (fr)
AT (1) AT402692B (fr)
BE (1) BE1006186A3 (fr)
CA (1) CA2122612C (fr)
CH (1) CH685282A5 (fr)
CZ (1) CZ282379B6 (fr)
DE (1) DE4232465B4 (fr)
DK (1) DK170832B1 (fr)
ES (1) ES2077530B1 (fr)
FI (1) FI114010B (fr)
FR (1) FR2683148B1 (fr)
GB (1) GB2276086B (fr)
HU (1) HU208084B (fr)
IT (1) IT1255390B (fr)
LU (1) LU88175A1 (fr)
NL (1) NL194664C (fr)
NO (1) NO307031B1 (fr)
SE (1) SE513624C2 (fr)
WO (1) WO1993008794A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0738114T3 (da) * 1994-01-06 2001-11-26 Hyd Kutato Fejleszto Ktf Næringsmiddelprodukt til forebyggelse af udvikling af sygdomme og fremgangsmåder til fremstilling af dette
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
ATE412906T1 (de) * 2002-02-12 2008-11-15 Univ California Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte
US20060094057A1 (en) 2002-07-30 2006-05-04 Maro K. Hellerstein Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
AU2002321678A1 (en) * 2002-09-09 2004-03-29 Boros Béla Oxygen-enriched water, treated within a magnetic field and heavy water
JP4610337B2 (ja) * 2002-09-13 2011-01-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗アテローム発生の指標としてのｉｎｖｉｖｏでの逆コレステロール輸送速度の測定方法
WO2004042360A2 (fr) 2002-11-04 2004-05-21 The Regents Of The Univeristy Of California Essai de tolerance au glucose deutere ou aux graisses pour la mesure a haute capacite du metabolisme des sucres ou des acides gras dans le corps
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (fr) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Composition pharmaceutique comprenant de l'eau appauvrie en isotopes lourds o17 et o8
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (fr) * 2004-06-03 2005-12-15 Kunihiro Seki Appareil de production d’un aliment a faible concentration de deuterium
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
BRPI0520020A2 (pt) * 2005-02-08 2009-04-14 Woodford Associates Ltd bebidas alccoólicas enriquecidas com 1h2 16o
RS20070331A (sr) * 2005-02-08 2009-03-25 Woodford Asociates Ltd., Bezalkoholno piće obogaćeno sa 1h216o
WO2006096082A1 (fr) * 2005-03-05 2006-09-14 Sergey Pavlovich Soloviev Composition cosmetique enrichie en 1h216o
EP1855699B1 (fr) * 2005-03-11 2012-08-15 Sergey Pavlovich Soloviev Eau pharmaceutique legere, compositions therapeutiques et procedes correspondants
CN101146448A (zh) * 2005-03-11 2008-03-19 维达咨询有限公司 用于消毒无生命表面的组合物
US20080103092A1 (en) * 2005-03-11 2008-05-01 Pomytkin Igor A Methods for Intradermal, Transdermal or Transmucosal Delivery of Biologically Active Substances
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
RU2287324C1 (ru) * 2005-04-29 2006-11-20 Тамази Владимирович Баззаев Мазь для лечения ожоговых ран
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
US20080299221A1 (en) * 2005-12-12 2008-12-04 Igor Anatolievich Pomytkin Method for Decreasing Postprandial Glucose Excursion
EA014535B1 (ru) * 2005-12-12 2010-12-30 Тимантти Аб Способ подавления аппетита и снижения объема поглощения пищи
US20080292719A1 (en) * 2005-12-12 2008-11-27 Igor Anatolievich Pomytkin Method of Treating Metabolic Syndrome
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE102009017966A1 (de) 2009-04-21 2010-11-04 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
JP6110846B2 (ja) * 2011-05-27 2017-04-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｃ型肝炎ウイルス阻害剤としての重水素が導入されたトリペプチド
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
WO2013036885A1 (fr) 2011-09-08 2013-03-14 The Regents Of The University Of California Mesure de flux métabolique, imagerie et microscopie
ES2668678T3 (es) 2011-12-07 2018-05-21 Glaxosmithkline Llc Procedimiento de determinación de la masa muscular esquelética corporal total
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150313266A1 (en) * 2012-12-03 2015-11-05 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
JP2017526638A (ja) * 2014-06-30 2017-09-14 ミトコンドリアル サブストレート インベンション リミテッドＭｉｔｏｃｈｏｎｄｒｉａｌ Ｓｕｂｓｔｒａｔｅ Ｉｎｖｅｎｔｉｏｎ Ｌｉｍｉｔｅｄ 認知機能向上のための栄養素溶液
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
AU2017329108B2 (en) * 2016-09-21 2022-07-07 Botanical Water Technologies Ip Ltd Isotopic compositions
CA3087342A1 (fr) * 2018-01-02 2019-07-11 Botanical Water Technologies Ip Ltd Eau enrichie d'isotopes
WO2019174659A1 (fr) 2018-03-15 2019-09-19 Karl Bau Gmbh Procédé et ensemble servant à fabriquer de l'eau à teneur réduite en deutérium
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用
CN120078803A (zh) * 2025-03-05 2025-06-03 江苏睿景生物技术有限公司 低氘水对肿瘤细胞生长抑制的作用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
EP0335918A1 (fr) * 1987-08-07 1989-10-11 Mallinckrodt Diagnostica (Holland) B.V. Composition diagnostique ou radiotherapeutique comprenant un compose a base d'hydrogene
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
FI114010B (fi) 2004-07-30
NL194664C (nl) 2002-11-04
DE4232465B4 (de) 2008-11-06
FR2683148B1 (fr) 1994-09-09
CH685282A5 (de) 1995-05-31
KR100253874B1 (ko) 2000-04-15
HU208084B (en) 1993-08-30
SE9401406L (sv) 1994-06-07
LU88175A1 (fr) 1993-03-15
GB2276086B (en) 1995-09-27
IT1255390B (it) 1995-10-31
WO1993008794A1 (fr) 1993-05-13
BE1006186A3 (fr) 1994-06-07
SE9401406D0 (sv) 1994-04-25
JPH08501275A (ja) 1996-02-13
CZ282379B6 (cs) 1997-07-16
FI941979A0 (fi) 1994-04-29
ITMI922233A0 (it) 1992-09-28
US5855921A (en) 1999-01-05
AT402692B (de) 1997-07-25
NL194664B (nl) 2002-07-01
FI941979L (fi) 1994-06-29
NO307031B1 (no) 2000-01-31
ES2077530A1 (es) 1995-11-16
DK170832B1 (da) 1996-02-05
CA2122612C (fr) 2003-02-04
GB2276086A (en) 1994-09-21
CZ102094A3 (en) 1994-12-15
GB9408654D0 (en) 1994-07-20
CA2122612A1 (fr) 1993-05-13
NO941590D0 (fr) 1994-04-29
ITMI922233A1 (it) 1994-03-28
FR2683148A1 (fr) 1993-05-07
KR930007461A (ko) 1993-05-20
NL9220026A (nl) 1994-09-01
CN1045162C (zh) 1999-09-22
DE4232465A1 (de) 1993-05-06
JP3569916B2 (ja) 2004-09-29
NO941590L (fr) 1994-06-23
CN1071836A (zh) 1993-05-12
ES2077530B1 (es) 1996-07-01
HU913437D0 (en) 1992-01-28
ATA902992A (de) 1996-12-15

Similar Documents

Publication Publication Date Title
JP3569916B2 (ja) 腫瘍の治療のための製薬学的製品とそれの製造方法
AU2010238308B2 (en) Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
CN112566514A (zh) 尿酸排出促进用组合物、urat1抑制用组合物及血液中尿酸值降低用组合物
JPWO2005074907A1 (ja) 遺伝子発現調節剤
KR101505903B1 (ko) 감수 추출물，이의 분획물 또는 이로부터 분리한 디테르펜 화합물을 유효성분으로 함유하는 창상 치료 또는 피부 활성용 약학적 조성물
JP5156298B2 (ja) 筋肉細胞糖輸送促進作用組成物
KR102521988B1 (ko) 감마-글루타밀티로신을 포함하는 암 치료 또는 예방용 약제학적 조성물
JP5295312B2 (ja) がん予防用液状組成物及びその製造方法
TWI698521B (zh) 植物發酵物及其用於調控ｃｄ３６基因、ａｂｃａ１基因、ｐｒｏｃ基因、ｖｗｆ基因、ｆ３基因、ｓｅｒｐｉｎｅ１基因、ｐｄｇｆｃ基因、ｆｇｆ２基因、ｉｇｆ２ｂｐ３基因、ｉｇｆ１ｒ基因、ｉｌ８基因、ｖｃａｍ１基因及ｃａｓｐ８基因的表現量及心血管保健的用途
KR102746020B1 (ko) 약쑥을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
KR20120044450A (ko) 대계 추출물을 포함하는 골다공증 예방 또는 치료용 조성물
KR102658030B1 (ko) 탈염 함초 추출물 또는 이의 분획물을 포함하는 골 질환 또는 갱년기 질환 예방, 치료 또는 개선용 조성물 및 이의 제조 방법
MXPA96003241A (en) Pharmaceutical products to cure tumor diseases and procedure for its preparation
KR20200082425A (ko) 방사선 내성 암 예방, 치료 또는 개선용 조성물 및 방사선 내성 암 예방 또는 치료용 물질 스크리닝 방법
KR101872770B1 (ko) 신규한 셀레노벤젠 화합물을 유효성분으로 함유하는 암의 예방 또는 치료용 조성물
JP2010280598A (ja) Ｌｋｂ１活性化剤
JP2025172328A (ja) Ｉｇｆ－１産生促進剤およびその応用
KR20220083325A (ko) 락토바실러스 사케이 배양액 유래 사이클로디펩티드계 화합물의 분리방법 및 이를 포함하는 골 질환 예방 또는 치료용 조성물
HK40047717A (en) Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid level
JP2019180260A (ja) 血中尿酸値低下剤及び血中尿酸値低下用飲食品組成物

Legal Events

Date Code Title Description
NUG Patent has lapsed